Research

Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA

Aside from impairment testing, Ontario-based Zentrela wants to work with cannabis producers to generate accurate product claims

Monthly cannabis sales dipped slightly in the shortest month of the year, but daily purchases were up 4%

Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy

Identifying specific terpene-cannabinoid combinations can create new ways to improve medical therapy, researchers suggest

Despite ongoing Covid-19 restrictions, data firms and cannabis companies report record sales on the stoner holiday

More alcohol, but not weed, use during youth is associated with thinning in parts of the brain associated with intelligence, impulsivity and risky behaviour

The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine

The resource-rich country produces less emissions than the US, but it's still a big problem that government isn't tracking and firms don't want to talk about

Canadian provinces are slowly easing strict marketing rules to be on par with alcohol and meet broader public policy goals, U of A prof says

Better data would allow researchers to test the effectiveness of regulations and lead to a more robust market overall, experts say

It's essential to test products pre-launch as they can create bad consumer experiences, says Nextleaf Solutions, which just got approved for human trials

Ontario led all provinces in Q4 with $251 million in legal weed sales, according to the OCS's latest quarterly report

Coming of legal age by the day, cannabis's fastest growing consumer demographic is motivated by identity formation, experts say

Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off

A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy

Despite new lockdown orders issued in some provinces, recreational weed sales climbed 14.3% in December to $298.4M

Pricing depends on various factors including competition, a spokesperson says, who confirmed no customer data was leaked

Maine-based Desert Harvest is working with university researchers to see if its CBD-aloe vera formula can treat pain more safely and effectively than opioids

While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment

Led by robust medical markets in Israel and Germany, 13,849 kg of dried flower and 10,494 L of oil was shipped out of country

In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications

With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field

From CBD drivers to stoner rats, legal reform continues to push weed research to an all-time high

Brock University's Michael Armstrong argues Canada's restrictive labelling rules incentivize producers to maximize THC content and minimize price

Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine

A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound

Lead researcher and Tilray VP Philippe Lucas says new data shows why Canada regulating weed on par with alcohol would reduce societal harms

A recent questionnaire highlights how a taxed system with strictly commercial access leaves patients treating themselves outside official channels

The data firm says it aims to re-establish access to supply chain information cut off by government distributors, empowering producers and retailers

Following the OCS's release of its first-quarter report this week, attorney Trina Fraser questions the ongoing lack of transparency

Figures from 2019 vary significantly with previous news reports, which could land Health Canada in hot water if it can't explain why

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Results should be used by policy makers to save lives during the overdose crisis, says cannabis and addiction scientist M-J Milloy

A detailed look at non-prescription cannabidiol in 9 countries reveals a regulatory hodgepodge outpaced by a wild west market

Projections from industry analysts, conflicting data and expert opinion call StatsCan's survey-based figures into question

Avail Cannabis clinic will monitor 30 veterans from Ont. or Man. for 3 months to see if symptoms improve

Director and producer David Jakubovic says stigma can be broken with just 5 minutes of being open to science

Data suggest gummies are primed to increase sales share and there's opportunity for new brands to enter the space

The trend emphasizes the need for online product info, which can cause a consumer to jump if not available, says branding expert